• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

75 岁以上食管癌患者行食管癌切除术的近期和远期疗效。

The Short- and Long-term Outcomes of Esophagectomy for Esophageal Cancer in Patients Older than 75 Years.

机构信息

Department of Surgery, Yokohama City University, Yokohama, Japan

Department of Surgery, Yokohama City University, Yokohama, Japan.

出版信息

Anticancer Res. 2020 Feb;40(2):1087-1093. doi: 10.21873/anticanres.14047.

DOI:10.21873/anticanres.14047
PMID:32014958
Abstract

BACKGROUND

The short- and long-term outcomes of esophagectomy for esophageal cancer were fully evaluated in patients older than 75 years of age.

PATIENTS AND METHODS

The present study selected patients who received esophagectomy for esophageal cancer. Patients were divided into non-elderly patients [age <75 years (non-elderly group)] and elderly patients [age ≥75 years (elderly group)]. The postoperative surgical morbidity, postoperative 30-days mortality, recurrence-free survival (RFS), and overall survival (OS) rates were evaluated between the non-elderly group and elderly group.

RESULTS

One hundred twenty-two patients were evaluated in this study. Ninety-eight patients and 24 patients were classified into the non-elderly group and elderly group, respectively. The postoperative surgical complication rates in the non-elderly and elderly groups were 71.4% and 75.0%. There was not a statistically significant difference between the two groups (p=0.710). Mortality was observed in 1 patient in the elderly group (4.2%) due to cardiovascular disease. Significant differences were observed in the five-year OS and RFS rates of the elderly and non-elderly groups (55.4% vs. 29.7%, p=0.0017 and 42.2% vs. 21.2%, p=0.0334, respectively).

CONCLUSION

Although the rate of postoperative surgical complications after esophagectomy for esophageal cancer was almost equal in the elderly and the non-elderly patients, significant differences were observed in the mortality and long-term outcomes of the two groups. Thus, the surgical strategy and perioperative care must be carefully planned for esophageal cancer patients older than 75 years of age.

摘要

背景

已经充分评估了 75 岁以上食管癌患者行食管癌切除术的短期和长期结果。

患者和方法

本研究纳入了行食管癌切除术的患者。患者分为非老年患者[年龄<75 岁(非老年组)]和老年患者[年龄≥75 岁(老年组)]。评估非老年组和老年组之间的术后手术发病率、术后 30 天死亡率、无复发生存率(RFS)和总生存率(OS)。

结果

本研究共评估了 122 例患者。98 例和 24 例患者分别归入非老年组和老年组。非老年组和老年组的术后手术并发症发生率分别为 71.4%和 75.0%。两组之间无统计学差异(p=0.710)。老年组有 1 例(4.2%)患者因心血管疾病死亡。老年组和非老年组的 5 年 OS 和 RFS 率有显著差异(55.4%比 29.7%,p=0.0017 和 42.2%比 21.2%,p=0.0334)。

结论

尽管老年患者和非老年患者行食管癌切除术的术后手术并发症发生率几乎相同,但两组的死亡率和长期结果存在显著差异。因此,对于 75 岁以上的食管癌患者,必须仔细规划手术策略和围手术期护理。

相似文献

1
The Short- and Long-term Outcomes of Esophagectomy for Esophageal Cancer in Patients Older than 75 Years.75 岁以上食管癌患者行食管癌切除术的近期和远期疗效。
Anticancer Res. 2020 Feb;40(2):1087-1093. doi: 10.21873/anticanres.14047.
2
15-Year Experience with Multimodality Therapy Including Esophagectomy for Elderly Patients with Locoregional Esophageal Cancer.15 年多模态治疗经验,包括老年人局部晚期食管癌的食管切除术。
J Am Coll Surg. 2021 Apr;232(4):580-588. doi: 10.1016/j.jamcollsurg.2020.11.027. Epub 2021 Feb 4.
3
Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis.选择性老年食管癌患者行食管次全切除术加系统性淋巴结清扫术的可行性:倾向评分匹配分析
BMC Surg. 2019 Oct 15;19(1):143. doi: 10.1186/s12893-019-0617-2.
4
Outcomes of elderly patients following thoracoscopic esophagectomy for esophageal cancer.老年患者胸腔镜食管癌根治术后的结果。
Langenbecks Arch Surg. 2023 Jan 23;408(1):56. doi: 10.1007/s00423-023-02797-5.
5
Clinical Outcome of Esophagectomy in Elderly Patients With and Without Neoadjuvant Therapy for Thoracic Esophageal Cancer.老年胸段食管癌患者接受与未接受新辅助治疗的食管切除术后的临床结局
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S794-801. doi: 10.1245/s10434-015-4769-8. Epub 2015 Jul 30.
6
Impact of Smoking Status on Perioperative Morbidity, Mortality, and Long-Term Survival Following Transthoracic Esophagectomy for Esophageal Cancer.吸烟状况对食管癌经胸食管切除术围手术期发病率、死亡率和长期生存的影响。
Ann Surg Oncol. 2021 Sep;28(9):4905-4915. doi: 10.1245/s10434-021-09720-6. Epub 2021 Mar 3.
7
Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.评估骨骼肌减少症对老年食管癌患者食管癌手术后不良结局的预测价值。
Ann Surg. 2018 Jun;267(6):1100-1104. doi: 10.1097/SLA.0000000000002252.
8
Physiology, not chronology, dictates outcomes after esophagectomy for esophageal cancer: outcomes in patients 80 years and older.生理学而非年龄决定食管癌患者食管切除术的预后:80 岁及以上患者的结局。
Ann Surg Oncol. 2013 Mar;20(3):1020-6. doi: 10.1245/s10434-012-2703-x. Epub 2012 Nov 2.
9
[Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].[Sweet术式与Ivor-Lewis术式治疗中下段食管鳞状细胞癌的疗效比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Sep 25;19(9):979-984.
10
The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.在高容量中心,微创食管切除术的实施并不影响短期结果。
Anticancer Res. 2013 May;33(5):2085-91.

引用本文的文献

1
Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age.75 岁以上可切除食管鳞癌患者行食管切除术和放化疗的生存结局。
Thorac Cancer. 2024 Jul;15(21):1656-1664. doi: 10.1111/1759-7714.15329. Epub 2024 Jun 19.
2
Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin.术前 FOLFOX 治疗方案在不适合顺铂治疗的可切除食管鳞癌患者中的安全性和短期疗效。
Esophagus. 2023 Jan;20(1):109-115. doi: 10.1007/s10388-022-00951-4. Epub 2022 Sep 1.
3
Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients.
食管癌:老年患者行食管癌切除术的结局和潜在获益。
Thorac Cancer. 2022 Oct;13(19):2699-2710. doi: 10.1111/1759-7714.14596. Epub 2022 Aug 24.
4
Management of elderly patients with esophageal squamous cell cancer.老年食管鳞癌患者的管理。
Jpn J Clin Oncol. 2022 Aug 5;52(8):816-824. doi: 10.1093/jjco/hyac067.
5
Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis.老年患者的食管癌:当前治疗选择与结果;系统评价与汇总分析
Cancers (Basel). 2021 Apr 27;13(9):2104. doi: 10.3390/cancers13092104.
6
The role of surgery type in postoperative atrial fibrillation and in-hospital mortality in esophageal cancer patients with preserved left ventricular ejection fraction.手术类型在左心室射血分数保留的食管癌患者术后房颤及院内死亡率中的作用。
World J Surg Oncol. 2020 Sep 11;18(1):244. doi: 10.1186/s12957-020-02011-6.
7
The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.年龄调整 Charlson 共病指数对接受根治性治疗的食管癌患者的临床影响。
In Vivo. 2020 Sep-Oct;34(5):2783-2790. doi: 10.21873/invivo.12103.
8
Photodynamic Therapy Using Talaporfin Sodium for Local Failure after Chemoradiotherapy or Radiotherapy for Esophageal Cancer: A Single Center Experience.使用替莫泊芬钠进行光动力疗法治疗食管癌放化疗或放疗后局部失败:单中心经验
J Clin Med. 2020 May 17;9(5):1509. doi: 10.3390/jcm9051509.